Please assess the completion status of the following clinical trial:

Trial Title: Thoracic Paravertebral Block in Pain Management After Renal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Age 18-75~* Scheduled for elective open nephrectomy or NSS~* Gave written consent~* BMI 19-30~* ASA status I-III~Exclusion criteria:~* Presence of chronic pain~* Chronic mental conditions (depression)~* Contraindications for PVB~* Chest or spine deformations~* Infection in planned site of PVB~* Allergies for drugs used in the study~* Cancer invading chest wall

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PVB group (Type: EXPERIMENTAL): Thoracic paravertebral blockade PVB (preoperatively) Bupivacaine WZF Sopodorm Propofol WZF Fentanyl WZF Nimbex Sevorane Intubation Oxynorm Ketonal Paracetamol Kabi
- GEN group (Type: OTHER): Sopodorm Propofol WZF Fentanyl WZF Nimbex Sevorane Intubation Oxynorm Ketonal Paracetamol Kabi

Based on this trial design, predict the completion outcome and termination type (if applicable).